Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alba Toll

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Psychiatry & Neuroscience : JPN|January 20, 2022
Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosisAlba Toll, Laura Blanco-Hinojo, Daniel Bergé, et al.
Journal of Affective Disorders|November 28, 2020
A multicenter, observational study of pain and functional impairment in individuals with major depressive disorder in partial remission: the DESIRE studyVíctor Pérez, Raúl Martínez-Navarro, Adrián Pérez-Aranda, et al.
Translational Psychiatry|March 31, 2026
Bioenergetic and early treatment response stratification (BIOERES): a two-variable prognostic model for early identification of treatment-resistance schizophreniaEloi Giné-Servén, Ester Boix-Quintana, Alejandro Ballesteros, et al.
Spanish Journal of Psychiatry and Mental Health|November 20, 2025
Assessment of prolactin levels and sexual dysfunction in patients on long-acting risperidone ISM vs monthly paliperidone palmitateJavier Labad, Vanesa Gálvez, Miriam Gregorio, et al.
Molecular Psychiatry|October 7, 2025
Differential effect of cannabis use and antipsychotic medication on extracellular free-water in the brain of individuals with early psychosis and controlsLaura Martínez-Sadurní, Marta Barrera-Conde, Patricia Robledo, et al.
Molecular and Cellular Biochemistry|July 13, 2023
Y-chromosome in the olfactory neuroepithelium as a potential biomarker of depression in women with male offspring: an exploratory studyPilar Álvarez, Beatriz Bellosillo, Francesc Colom, et al.
Spanish Journal of Psychiatry and Mental Health|June 22, 2024
Clozapine use in the first two years after first-episode psychosis in a real-world clinical sampleEmilio Pechuán, Alba Toll, Daniel Bergé, et al.
Schizophrenia Research|October 16, 2018
Influence of secondary sources in the Brief Negative Symptom ScaleDevi Treen, George Savulich, Gisela Mezquida, et al.
Spanish Journal of Psychiatry and Mental Health|December 10, 2020
The Suicide Prevention and Intervention Study (SURVIVE): Study protocol for a multisite cohort study with nested randomized-controlled trialsVíctor Pérez, Matilde Elices, Alba Toll, et al.
Journal of Affective Disorders|October 25, 2020
Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorderYolanda Sánchez-Carro, Maria J Portella, Itziar Leal-Leturia, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Psychiatry & Neuroscience : JPN|January 20, 2022
Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosisAlba Toll, Laura Blanco-Hinojo, Daniel Bergé, et al.
Journal of Affective Disorders|November 28, 2020
A multicenter, observational study of pain and functional impairment in individuals with major depressive disorder in partial remission: the DESIRE studyVíctor Pérez, Raúl Martínez-Navarro, Adrián Pérez-Aranda, et al.
Translational Psychiatry|March 31, 2026
Bioenergetic and early treatment response stratification (BIOERES): a two-variable prognostic model for early identification of treatment-resistance schizophreniaEloi Giné-Servén, Ester Boix-Quintana, Alejandro Ballesteros, et al.
Spanish Journal of Psychiatry and Mental Health|November 20, 2025
Assessment of prolactin levels and sexual dysfunction in patients on long-acting risperidone ISM vs monthly paliperidone palmitateJavier Labad, Vanesa Gálvez, Miriam Gregorio, et al.
Molecular Psychiatry|October 7, 2025
Differential effect of cannabis use and antipsychotic medication on extracellular free-water in the brain of individuals with early psychosis and controlsLaura Martínez-Sadurní, Marta Barrera-Conde, Patricia Robledo, et al.
Molecular and Cellular Biochemistry|July 13, 2023
Y-chromosome in the olfactory neuroepithelium as a potential biomarker of depression in women with male offspring: an exploratory studyPilar Álvarez, Beatriz Bellosillo, Francesc Colom, et al.
Spanish Journal of Psychiatry and Mental Health|June 22, 2024
Clozapine use in the first two years after first-episode psychosis in a real-world clinical sampleEmilio Pechuán, Alba Toll, Daniel Bergé, et al.
Schizophrenia Research|October 16, 2018
Influence of secondary sources in the Brief Negative Symptom ScaleDevi Treen, George Savulich, Gisela Mezquida, et al.
Spanish Journal of Psychiatry and Mental Health|December 10, 2020
The Suicide Prevention and Intervention Study (SURVIVE): Study protocol for a multisite cohort study with nested randomized-controlled trialsVíctor Pérez, Matilde Elices, Alba Toll, et al.
Journal of Affective Disorders|October 25, 2020
Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorderYolanda Sánchez-Carro, Maria J Portella, Itziar Leal-Leturia, et al.
Pageof 4